DR. LAL PATHLABS
Sector : Pharmaceuticals and health care | Midcap | BSE
Here's the live share price of Dr. Lal Pathlabs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-1.08₹ -35.3
As on Sep 17, 2025, 4:01 PM IST
Dr. Lal Pathlabs Price Performance
Today's LowToday's High
₹3,237.10₹3,290.45
₹3,237.10
52 Weeks' Low52 Weeks' High
₹2,295.10₹3,645.00
₹3,237.10
Open Price
₹3,272.80
Prev. Close
₹3,272.40
Volume
2,320
Over the last 5 years, the share price of Dr. Lal Pathlabs has gained 10.37% CAGR. Over the past year, the corresponding return has been -1.33%.
Dr. Lal Pathlabs’s current P/E of 52.85x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Dr. Lal Pathlabs Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Dr. Lal Pathlabs | 0.38 | -5.55 | 10.61 | 27.35 | -1.33 | 12.37 | 10.37 |
| Apollo Hospitals Enterprise | -0.67 | 0.67 | 12.41 | 27.95 | 12.41 | 22.27 | 34.68 |
| Max Healthcare Institute | -2.35 | -4.82 | -5.90 | 15.52 | 19.51 | 39.50 | 57.81 |
| Fortis Healthcare | -0.03 | 3.16 | 26.92 | 61.65 | 60.01 | 44.48 | 48.36 |
| Global Health | 0.92 | 2.75 | 16.35 | 17.07 | 22.63 | 49.18 | 27.12 |
| Narayana Hrudayalaya | 1.57 | -1.28 | -4.88 | 14.52 | 41.05 | 37.68 | 39.58 |
| Aster DM Healthcare | -4.19 | -1.48 | 8.19 | 44.36 | 48.69 | 35.10 | 35.11 |
| Krishna Institute of Medical Sciences | -1.42 | -2.22 | 12.88 | 25.08 | 32.54 | 45.13 | 30.19 |
| Rainbow Childrens Medicare | -1.43 | -5.65 | 3.47 | 17.34 | 11.67 | 31.31 | 26.67 |
| Dr. Agarwals Health Care | 4.09 | 1.28 | 11.86 | 6.12 | 10.04 | 3.24 | 1.93 |
| Vijaya Diagnostic Centre | -0.04 | -0.82 | 10.66 | -1.93 | 15.28 | 38.06 | 11.13 |
| Metropolis Healthcare | -4.37 | -4.86 | 21.69 | 28.38 | -5.67 | 15.67 | 1.36 |
| Jupiter Life Line Hospitals | -1.44 | 2.61 | -4.79 | -4.78 | 5.97 | 10.57 | 6.22 |
| Healthcare Global Enterprises | -3.47 | 0.58 | 24.06 | 35.03 | 61.67 | 37.07 | 40.69 |
| Yatharth Hospital & Trauma Care Services | 0.33 | 12.76 | 53.82 | 115.49 | 46.25 | 33.83 | 19.11 |
| Kovai Medical Center and Hospital | -0.76 | -3.47 | 7.64 | 17.50 | 14.75 | 60.29 | 51.83 |
| Thyrocare Technologies | -6.80 | -13.76 | 20.27 | 67.34 | 41.12 | 19.56 | 8.45 |
| Indraprastha Medical Corporation | -4.65 | 4.66 | 18.73 | 48.67 | 6.08 | 93.59 | 56.71 |
| Artemis Medicare Services | 2.20 | 0.02 | -3.80 | 2.76 | -16.52 | 56.82 | 70.50 |
| Krsnaa Diagnostics | 0.28 | 3.08 | 26.59 | 18.87 | 3.28 | 20.56 | -3.02 |
Over the last one year, Dr. Lal Pathlabs has declined 1.33% compared to peers like Apollo Hospitals Enterprise (12.41%), Max Healthcare Institute (19.51%), Fortis Healthcare (60.01%). From a 5 year perspective, Dr. Lal Pathlabs has underperformed peers relative to Apollo Hospitals Enterprise (34.68%) and Max Healthcare Institute (57.81%).
Dr. Lal Pathlabs Financials
Dr. Lal Pathlabs Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 3,262.17 | 3,279.58 |
| 10 | 3,264.75 | 3,276.78 |
| 20 | 3,311.9 | 3,269.52 |
| 50 | 3,162.4 | 3,176.7 |
| 100 | 2,995.89 | 3,055 |
| 200 | 2,876.63 | 2,956.73 |
Dr. Lal Pathlabs Share Holding Pattern
In the latest quarter, Dr. Lal Pathlabs saw a drop in promoter holding to 53.79%, while DII stake increased to 17.91%, FII holding fell to 21.69%, and public shareholding moved up to 6.22% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Dr. Lal Pathlabs Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| HDFC Flexi Cap Fund - Regular Plan | 21,00,000 | 0.85 | 694.87 |
| UTI Flexi Cap Fund | 12,46,577 | 1.62 | 412.48 |
| Aditya Birla Sun Life Flexi Cap Fund | 7,61,634 | 1.1 | 252.02 |
| SBI Large & Midcap Fund | 6,50,000 | 0.65 | 215.08 |
| Nippon India Small Cap Fund | 6,45,485 | 0.33 | 213.58 |
| Nippon India Pharma Fund | 6,09,112 | 2.41 | 201.55 |
| HDFC ELSS Tax Saver Fund | 5,70,000 | 1.14 | 188.61 |
| Sundaram Mid Cap Fund | 5,15,995 | 1.37 | 170.74 |
| UTI Mid Cap Fund | 4,11,730 | 1.17 | 136.24 |
| PGIM India Midcap Opportunities Fund | 3,88,808 | 1.13 | 128.65 |
Dr. Lal Pathlabs Futures
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Dr. Lal Pathlabs Options
Dr. Lal Pathlabs Corporate Actions
Date Time | Announcement |
|---|---|
| Aug 26, 2025, 5:19 PM IST | Dr. Lal Pathlabs Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Aug 20, 2025, 4:07 PM IST | Dr. Lal Pathlabs Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Aug 05, 2025, 11:45 PM IST | Dr. Lal Pathlabs Ltd - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Aug 01, 2025, 12:44 AM IST | Dr. Lal Pathlabs Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Jul 31, 2025, 7:20 PM IST | Dr. Lal Pathlabs Ltd - Announcement under Regulation 30 (LODR)-Investor Presentation |
About Dr. Lal Pathlabs
Dr. Lal Pathlabs Ltd. is a Public Limited Listed company incorporated on 14/02/1995 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1995PLC065388 and registration number is 065388. Currently Company is involved in the business activities of Other human health activities. Company's Total Operating Revenue is Rs. 2351.62 Cr. and Equity Capital is Rs. 83.59 Cr. for the Year ended 31/03/2025.
- IndustryHospitals & Medical Services
- AddressBlock E, New Delhi Delhi 110085
- Contact
Management
- Brig.(Hony) Dr. Arvind LalExecutive Chairman
- Dr. Vandana LalWhole Time Director
- Dr. Archana Lal ErdmannNon Executive Director
- Mr. Rahul SharmaNon Executive Director
- Mr. Arun DuggalIndependent Director
- Mr. Gurinder Singh KalraIndependent Director
- Mr. Rajit MehtaIndependent Director
- Mrs. Somya SatsangiIndependent Director
- Mr. Rohit BhasinIndependent Director
FAQs on Dr. Lal Pathlabs Share Price
What is the share price of Dr. Lal Pathlabs?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Dr. Lal Pathlabs is ₹3,237.10 as on Sep 17, 2025.
What kind of stock is Dr. Lal Pathlabs?
The Dr. Lal Pathlabs is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
What is the Market Cap of Dr. Lal Pathlabs?
The market cap of Dr. Lal Pathlabs is ₹27,118.97 Cr as on Sep 17, 2025.
What are today's High and Low prices of Dr. Lal Pathlabs?
Today’s highest and lowest price of Dr. Lal Pathlabs are ₹3,290.45 and ₹3,237.10.
What are the 52 Week High and 52 Week Low of Dr. Lal Pathlabs?
The 52-week high/low is the highest and lowest price at which Dr. Lal Pathlabs stock has traded in the past 52-week or nearly a year. The 52-week high of Dr. Lal Pathlabs is ₹3,645.00 and 52-week low of Dr. Lal Pathlabs is ₹2,295.10 as on Sep 17, 2025.
How has the Dr. Lal Pathlabs performed historically in terms of returns?
The Dr. Lal Pathlabs has shown returns of -1.08% over the past day, -5.55% for the past month, 10.61% over 3 months, -1.33% over 1 year, 12.37% across 3 years, and 10.37% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Dr. Lal Pathlabs?
P/E ratio of and PB ratio of Dr. Lal Pathlabs are 52.85 and 13.55 on Sep 17, 2025. While the company gives a dividend yield of 0.74 per annum.
Trending In Market
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data